Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2002
08/08/2002US20020106649 Detecting preferential nucleotide sequences in sample; obtain sample nucleotide, incubate with preferential probe, detect signal
08/08/2002US20020106647 Nucleotide sequences for use in the treatment of antherosclerosis, autoimmune and inflammatory disorders
08/08/2002US20020106646 Classifying preferential bacteria; obtain sample, incubate with primer, screen sample for signal, presence of signal indicates staphylococcus
08/08/2002US20020106645 Detecting preferential psychological disorders; obtain tissue sample, detect sequences polymorphism, presence of polymorphism indicates psychological disorders
08/08/2002US20020106643 Detecting preferential receptor; obbtain cells, transform, generate retroviral particles, recovering vectors
08/08/2002US20020106642 Protease for use in the treatment and prevention of viral disease and infections
08/08/2002US20020106641 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine
08/08/2002US20020106639 Postweaning multisystemic wasting syndrome virus from pigs
08/08/2002US20020106638 Process for typing of HCV isolates
08/08/2002US20020106636 Monoclonal antibodies to human immunodeficiency virus and uses thereof
08/08/2002US20020106635 Cytokine resistant cytomegalovirus promoter mutants and related products and methods
08/08/2002US20020106633 Vitro assay for testing gabapentinoid activity
08/08/2002US20020106632 Detecting modulators of gene expression; obtain cell, transform cell, with vector, incubate cell with modulator, monitor gene activity of cell
08/08/2002US20020106631 Recombinant, active caspases and uses thereof
08/08/2002US20020106629 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin
08/08/2002US20020106628 Methods of modifying eukaryotic cells
08/08/2002US20020106382 Modified adenovirus and uses thereof
08/08/2002US20020106378 Materials and methods for intracellular transport and their uses
08/08/2002US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura
08/08/2002US20020106370 Improvements in or relating to peptide delivery
08/08/2002US20020106356 Secreted proteins
08/08/2002US20020106355 Novel regulatory sequences of the MCP-1 gene
08/08/2002US20020106354 Cellular and animal models for diseases associated with altered mitochondrial function
08/08/2002US20020106351 Bacterium NRRL B-30043 for controlling algae
08/08/2002US20020106349 Dilute viral suspension is prepared corresponding to the dilution of a viral suspension in an aqueous solution containing salt or hexose; dilute viral suspension is nebulized pressurized gas of or an ultrasound frequency
08/08/2002US20020106323 Natural killer cell enhancing factor C
08/08/2002DE10104952A1 Vektorsystem zum Screening von Wirkstoffen Vector system for screening active substances
08/08/2002DE10104871A1 Verfahren zur Kontrolle von Schadorganismen in Nutzpflanzenkulturen A method of controlling pests in crops
08/08/2002CA2784251A1 Focused libraries of genetic packages
08/08/2002CA2766160A1 Molecules with extended half-lives, compositions and uses thereof
08/08/2002CA2472051A1 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep)
08/08/2002CA2454215A1 Polymers
08/08/2002CA2437342A1 Method for producing recombinant trypsin
08/08/2002CA2437121A1 Juvenile hormone esterase
08/08/2002CA2437072A1 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
08/08/2002CA2437044A1 Method of determining a chemotherapeutic regimen based on ercc1 expression
08/08/2002CA2437016A1 Screening method for infection agent of prion disease
08/08/2002CA2436773A1 Human protein kinase n-like polypeptide and uses thereof
08/08/2002CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk)
08/08/2002CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells
08/08/2002CA2436661A1 Novel nucleic acid and polypeptide molecules
08/08/2002CA2436530A1 Environmentally regulated genes of streptococcus suis
08/08/2002CA2436528A1 Fungal resistant transgenic plants
08/08/2002CA2436488A1 Method for carrying out a biochemical protocol in continuous flow in a microreactor
08/08/2002CA2436487A1 Methods of inhibiting kinases
08/08/2002CA2436428A1 Methods of analysis of nucleic acids
08/08/2002CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002CA2436092A1 Modified antibodies and methods of use
08/08/2002CA2435770A1 Detection of methylated cpg rich sequences diagnostic for malignant cells
08/08/2002CA2435682A1 Computer-assisted means for assessing lifestyle risk factors
08/08/2002CA2434968A1 Method for the evolutionary design of biochemical reaction networks
08/08/2002CA2434953A1 Protein modification and maintenance molecules
08/08/2002CA2434854A1 Hybridization buffers using low molecular weight dextran sulfate and methods for their use
08/08/2002CA2434822A1 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
08/08/2002CA2434626A1 Microorganisms and processes for enhanced production of pantothenate
08/08/2002CA2434293A1 Fluorescent proteins
08/08/2002CA2434097A1 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
08/08/2002CA2433842A1 Expression of multiple proteins in transgenic plants
08/08/2002CA2433532A1 Transgenic plants containing altered levels of steroid compounds
08/08/2002CA2432973A1 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
08/08/2002CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
08/08/2002CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
08/08/2002CA2430921A1 Use of a vector encoding a ghrh peptide to enhance growth in multiple litters of offspring from female animals
08/08/2002CA2430886A1 Compositions and methods for rapidly generating recombinant nucleic acid molecules
08/08/2002CA2430653A1 Transfection of human embryonic stem cells
08/08/2002CA2428732A1 Methods and kit for simultaneous screening of interactions between a plurality of chemical or biological species and uses thereof
08/08/2002CA2428248A1 Solubility reporter gene constructs
08/08/2002CA2427143A1 Compositions and methods for improving kidney function
08/08/2002CA2426856A1 Thuja plicata dirigent protein promoters
08/08/2002CA2426818A1 Control of gene expression in plants
08/08/2002CA2426582A1 Gene delivery formulations and methods for treatment of ischemic conditions
08/08/2002CA2425798A1 Methods for determining protein and peptide terminal sequences
08/08/2002CA2332186A1 Replicative in vivo gene targeting
08/07/2002EP1229593A1 Photodetector
08/07/2002EP1229332A2 In vitro assay for testing gabapentinoid activity
08/07/2002EP1229134A2 Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
08/07/2002EP1229133A2 Nucleic acid sequence analysis
08/07/2002EP1229130A2 Tests based on nucleic acids of endosymbiont cellular organelles and compounds identifiable therewith
08/07/2002EP1229129A2 Affinity detecting/analytical chip, method for production thereof, detection method and detection system using same
08/07/2002EP1229124A1 Nucleic acid transporter containing polypeptide and recombinant virus vector
08/07/2002EP1229123A2 Method for producing polyester biopolymers
08/07/2002EP1229122A2 Chimeric isoprenoid synthases and uses thereof
08/07/2002EP1229121A2 Method for producing L-glutamine by fermentation and L-glutamine producing bacterium
08/07/2002EP1229120A1 A method for producing seeds having altered protein/fatty acid composition
08/07/2002EP1229119A1 PHOTOSENSITIVITY GENE Hd1 OF PLANT AND UTILIZATION THEREOF
08/07/2002EP1229118A1 Photosensitivity gene of plant and utilization thereof
08/07/2002EP1229117A2 Crystals of the human TRAIL/sDR5 (TNF-related apoptosis-inducing ligand/extracellular domain of DR5 receptor) complex, their three-dimensional structure and uses thereof
08/07/2002EP1229116A1 Method for preparing cell fraction containing hemangioblasts
08/07/2002EP1229115A1 Novel c-type lectin and gene thereof
08/07/2002EP1229114A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin
08/07/2002EP1229113A2 Recombinational cloning using engineered recombination sites
08/07/2002EP1229047A2 IL-1 Receptor fusion proteins used as antagonists and methods of making and using
08/07/2002EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells
08/07/2002EP1228768A1 Medicament for the protection against thrombotic diseases
08/07/2002EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules
08/07/2002EP1228248A2 Direct mapping of dna chips to detector arrays
08/07/2002EP1228247A2 Method for the controlled implementation of complex pcr amplifications
08/07/2002EP1228246A2 Method for distinguishing 5-position methylation changes
08/07/2002EP1228244A1 Methods and apparatuses for analyzing polynucleotide sequences
08/07/2002EP1228242A2 Methods for detection of a target nucleic acid sequence